Stock Highlights: SunEdison, Inc. (NYSE:SUNE), Gilead Sciences Inc. (NASDAQ:GILD), Symantec Corporation (NASDAQ:SYMC), Luminex Corporation (NASDAQ:LMNX), ProQR Therapeutics N.V. (NASDAQ:PRQR)

On 31 July, SunEdison, Inc. (NYSE:SUNE) and TerraForm Global, Inc. (“TerraForm Global”) announced today that TerraForm Global, a subsidiary of SunEdison, has priced an underwritten initial public offering of 45,000,000 shares of its Class A common stock at a price to the public of $15.00 per share, representing gross proceeds of $675 million. SunEdison, Inc. (NYSE:SUNE) belongs to Technology sector. Its net profit margin is -41.60% and weekly performance is -12.98%. On last trading day company shares ended up $22.45. SunEdison, Inc. (NYSE:SUNE) distance from 50-day simple moving average (SMA50) is -24.19%.

On 28 July, Gilead Sciences Inc. (NASDAQ:GILD) reported adjusted second-quarter earnings of $3.15 per share on $8.24 billion in revenue. Analysts had expected the company to report earnings of $2.71 a share on $7.61 billion in revenue, according to a consensus estimate from Thomson Reuters. Gilead Sciences Inc. (NASDAQ:GILD) shares decreased -0.61% in last trading session and ended the day at $118.87. GILD Gross Margin is 86.50% and its return on assets is 42.70%. Gilead Sciences Inc. (NASDAQ:GILD) quarterly performance is 15.84%.

On 29 July, Symantec Corporation (NASDAQ:SYMC) announced its support for The Equality Act, comprehensive federal LGBT non-discrimination legislation. On 04 August, Symantec Corporation (NASDAQ:SYMC) shares decreased -0.27% and was closed at $22.42. SYMC EPS growth in last 5 year was 7.70%. Symantec Corporation (NASDAQ:SYMC) year to date (YTD) performance is -11.56%.

On 3 August, Luminex Corporation (NASDAQ:LMNX) announced financial results for the second quarter ended June 30, 2015 Grew second quarter 2015 assay revenue by 22 percent to $24.2 million over results from the second quarter of 2014.Luminex Corporation (NASDAQ:LMNX) ended the last trading day at $20.21. Company weekly volatility is calculated as 4.50% and price to cash ratio as 9.16. Luminex Corporation (NASDAQ:LMNX) showed a weekly performance of 13.48%.

Zacks cut shares of ProQR Therapeutics N.V. (NASDAQ:PRQR) from a buy rating to some hold rating in a resaerch notice published onMonday morning. ProQR Therapeutics N.V. (NASDAQ:PRQR) shares increased 0.12% in last trading session and ended the day at $17.00. PRQR return on assets is -12.20%. ProQR Therapeutics N.V. (NASDAQ:PRQR) quarterly performance is -10.99%.

Leave a Reply

Your email address will not be published. Required fields are marked *